MED — Medifast Balance Sheet
0.000.00%
- $142.00m
- -$20.67m
- $602.46m
- 99
- 91
- 69
- 99
Annual balance sheet for Medifast, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 174 | 110 | 87.7 | 150 | 162 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.584 | 0.945 | 0 | 8.73 | 0 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 234 | 307 | 223 | 224 | 214 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 38.1 | 80.6 | 75.6 | 67.1 | 48.7 |
| Other Long Term Assets | |||||
| Total Assets | 276 | 398 | 316 | 310 | 284 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 111 | 170 | 141 | 92.3 | 64.2 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 119 | 196 | 161 | 108 | 74.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 157 | 202 | 155 | 201 | 210 |
| Total Liabilities & Shareholders' Equity | 276 | 398 | 316 | 310 | 284 |
| Total Common Shares Outstanding |